Greenphire Named One of the Fastest-Growing U.S Companies
News Aug 21, 2013
The company has been ranked 192, and 21 in the software industry, on the seventh annual list which represents the most comprehensive look at America's independent entrepreneurs.
Sam Whitaker, CEO, Greenphire, comments: "We are delighted to have made this year's Inc. 500. The Greenphire team has worked relentlessly to achieve our success and we are proud to have joined the ranks with many of the nation's most high achieving and innovative companies."
Since Greenphire was founded in 2008, the business has gone from strength-to-strength, launching two groundbreaking clinical payment technologies and securing contracts with multiple top 30 pharmaceutical companies. In the past 12 months alone, Greenphire has more than doubled its team and has established strategic partnerships with a number of leading organizations.
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Cancer Cells Force Normal Cells to Act Like Viruses, Helping Tumors SpreadNews
Researchers reveal how cancer cells force normal cells to act like viruses – allowing tumors to grow, resist treatment, and spread.READ MORE
Edith Heard Unanimously Selected as Next Director General of EMBLNews
At its 53rd meeting yesterday, EMBL Council selected Edith Heard as the organization’s fifth Director General. Heard’s mandate is scheduled to begin 1 January 2019.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018